CNE100004ZP2
CNE100004ZP2
LIAONING CHENGDA BIOTECHNOLOGY
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.390.287.449 | 1.676.241.144 | 17.1% |
| Cost of Revenue | 286.816.834 | 286.002.805 | 0.3% |
| Gross Profit | 1.103.470.615 | 1.390.238.338 | 20.6% |
| 906.490.786 | 936.682.137 | 3.2% | |
| Operating Income | 196.979.829 | 453.556.201 | 56.6% |
| Pretax Income | 169.604.544 | 403.024.938 | 57.9% |
| Net Income Common Stockholders | 131.790.329 | 342.821.554 | 61.6% |
| -- | -- | -- | |
| -- | -- | -- |